The health benefits and risks of dietary supplement use are controversial.
A recent study found that more than half of U.S. adults reported use of dietary supplements in the previous 30 days (1) . Whether dietary supplement use is associated with health benefits or risks is controversial. The overall evidence suggests no benefits or harms, but a few randomized controlled trials have reported adverse outcomes associated with dietary supplement use, especially at high doses (2, 3) . For example, the ATBC (AlphaTocopherol, Beta-Carotene Cancer Prevention) study and CARET (Beta-Carotene and Retinol Efficacy Trial) found that ␤-carotene supplements (20 or 30 mg/d) increased risk for lung cancer among smokers (4, 5) , and SELECT (Selenium and Vitamin E Cancer Prevention Trial) reported that supplemental use of vitamin E (400 IU/d) increased risk for prostate cancer among men (6) .
Although randomized controlled trials usually assess dietary supplement use at a specific dose, prospective cohort studies allow for evaluation of dose dependence versus threshold effects and potential heterogeneous effects of nutrient intake from supplements versus foods (7) . For example, the CPS-II (Cancer Prevention Study II) Nutrition Cohort found that higher doses of supplemental calcium (≥1000 mg/d) were associated with increased risk for allcause death in men, but lower doses (<1000 mg/d) or calcium intake from foods were not associated with mortality outcomes (8) . Therefore, both the dose of the supplement and the nutrient source (foods vs. supplements) can play critical roles in determining the benefits or risks of nutrient intake.
Using a nationally representative sample of U.S. adults, we evaluated the association between dietary supplement use and mortality from all causes, cardiovascular disease (CVD), and cancer. We further assessed whether adequate or excess nutrient intake was associated with mortality and whether the associations differed by nutrient intake from foods versus supplements.
METHODS

Study Design and Population
We used data from U.S. adults aged 20 years or older who participated in 6 cycles (1999 -2000 to 2009 -2010) of NHANES (National Health and Nutrition Examination Survey). Exclusion of pregnant or lactating women resulted in 30 958 participants, among whom 30 899 provided complete information on dietary supplement use in the previous 30 days. Those who responded "refused" or "don't know" or did not answer the questions on dietary supplement use were excluded (n = 59). Among the 30 899 participants who provided information on dietary supplement use, 27 725 with 1 or 2 valid 24-hour diet recalls were in-ORIGINAL RESEARCH
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cluded in the analysis that estimated nutrient intake from foods versus supplements and its association with mortality outcomes. NHANES was approved by the research ethics review board of the National Center for Health Statistics, and all participants provided written informed consent.
Dietary Supplement Use
NHANES participants were asked during an inhouse interview whether they had used any dietary supplements in the previous 30 days. Those who reported supplement use were asked about the product name, frequency (for example, how many times each day), duration (for example, how many days in the previous 30 days), and serving form (for example, capsules, tablets, pills, softgels, or drops). For each nutrient, the daily dose was calculated by combining the frequency (for example, the number of capsules taken each day) with the product information on the ingredient (for example, vitamin D or calcium), the amount per serving, and the units (for example, international units or milligrams). Nutrient intake from each product was summed to estimate the total daily dose of each supplemental nutrient for each participant (Appendix 1, available at Annals.org).
Nutrient Intake From Foods
Nutrient intake from foods was assessed using 24-hour diet recalls conducted by trained interviewers. One diet recall was done in person at the Mobile Examination Center; from 2003 to 2010, a second recall was added by telephone interview approximately 3 to 10 days after the first one. Using the Automated Multiple-Pass Method, all foods and beverages consumed the previous day were recorded. A standard set of measuring guides was used to help the respondent report the volume and dimensions of the items consumed. Food intakes were coded and nutrient values were determined using the U.S. Department of Agriculture Food and Nutrient Database for Dietary Studies (FNDDS), versions 1.0 to 5.0 (9) .
Inadequate and Excess Nutrient Intake
Inadequate nutrient intake was defined as levels of total nutrient intake (foods plus supplements) below the Estimated Average Requirement or the Adequate Intake level specified in the Dietary Reference Intakes (10) . Excess nutrient intake was defined as levels above the Tolerable Upper Intake Level.
Mortality
Mortality outcomes were obtained for each participant through linkage to the National Death Index through 31 December 2011 using a probabilistic match (11) . The International Classification of Diseases, 10th Revision (ICD-10), was used to ascertain cause-specific death. Death due to CVD was defined as ICD-10 codes I00 to I09, I11, I13, I20 to I51, or I60 to I69 being listed as the underlying cause of death, and death due to cancer was defined as codes C00 to C97 being listed as the underlying cause. Follow-up length was defined as the interval from the interview date to the date of death or to the end of 2011 for those who were censored.
Demographic Characteristics, Lifestyle Factors, and Comorbid Conditions
Demographic characteristics and lifestyle factors, including age, sex, race/ethnicity, education, income, smoking, and physical activity, were collected during household interviews. Alcohol intake, weight, and height were obtained during physical examinations at the Mobile Examination Center. Smokers were defined as participants who reported smoking at least 100 cigarettes during their lifetime, and former smokers were defined as those who reported smoking at least 100 cigarettes but were not currently smoking. Drinkers were defined as participants who consumed at least 12 alcoholic drinks in a given year. Moderate versus heavy drinkers were defined as participants who consumed fewer than 1 versus 1 or more drinks per day (women) or fewer than 2 versus 2 or more drinks per day (men). Participants were classified as physically active if they had at least 150 minutes of moderate to vigorous physical activity per week and were classified as physically inactive otherwise (12) . Diet quality was assessed using the Healthy Eating Index-2015, which measures adherence to the 2015-2020 Dietary Guidelines for Americans (13) . A higher score corresponds to a healthier diet. Comorbid conditions, including cancer, congestive heart failure, coronary heart disease, myocardial infarction, and stroke, were defined if participants reported having ever been told by a physician that they had these conditions and/or if they had ever been told to take or were currently taking prescription medication to treat high cholesterol, hypertension, or diabetes.
Statistical Analysis
We first estimated the prevalence of supplement use among the participants. Multivitamin and mineral (MVM) supplement use was defined as use of a product formulated with 3 or more vitamins with or without minerals (14) . We then compared the distribution of demographic characteristics, lifestyle factors, and comorbid conditions between participants who used any dietary supplements and those who did not, using t tests for continuous variables and 2 tests for categorical variables. We further estimated total nutrient intake by summing intake from foods and supplements and the percentage of participants with inadequate or excess intake. To correct for measurement error associated with use of 1-or 2-day recalls to estimate dietary intake, we used the National Cancer Institute (NCI) method to adjust for usual intake estimates. The method also uses regression calibration to correct for bias due to mea conditions. Multiple imputation was done for alcohol intake (6.1% missing values), the only variable missing more than 5% of values among participants who reported nutrient intake from both foods and supplements. We further evaluated whether the association differed by nutrient intake from supplements versus foods by including intake from both sources as separate variables in the same model. We also performed subgroup analysis among participants with or without comorbid conditions at baseline and among those with high (at or above the median) versus low (below the median) nutrient intake from foods at baseline. Sampling weights were adjusted in all analyses to account for unequal probabilities of sample selection due to complex sample design and oversampling of certain subgroups. The analyses for estimating nutrient intake from foods and supplements and the percentage of participants with inadequate or excess intake were conducted using SAS, version 9.4 (SAS Institute), and the analyses for estimating mortality rates, RRs, and rate differences (RDs) were done using Stata, version 15.1 (StataCorp). A P value less than 0.05 was considered statistically significant.
Role of the Funding Source
The funding source had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.
RESULTS
More than half of participants (51.2%) reported use of dietary supplements in the previous 30 days, and 38.3% reported use of MVM supplements. Compared with nonusers, supplement users were older and were more likely to be female and non-Hispanic white, have higher levels of education and family income, eat a healthy diet, and be physically active. They were also less likely to be current smokers, heavy drinkers, or obese but reported a higher prevalence of comorbid conditions at baseline ( Table 1) .
The most commonly used vitamin supplements were vitamin C (40.3% [95% CI, 39.3% to 41.4%]), vitamin E (38.6% [CI, 37.6% to 39.6%]), and vitamin D (37.6% [CI, . Levels of total nutrient intake were higher among supplement users than nonusers for all 25 nutrients. When nutrient intake from supplements was not accounted for, supplement users still had higher intake levels from foods for 23 nutrients ( Table 2) . Table 4) . Similarly, the lower CVD mortality associated with adequate intake of vitamin A, vitamin K, zinc, and copper was restricted to intake from foods (Appendix Table 2 ). However, the higher cancer mortality associated with excess calcium intake was attributable to high doses from supplements rather than foods. Supplemental calcium intake of 1000 mg/d or higher was associated with increased risk for cancer death (RR, 1.53 [CI, 1.04 to 2.25]; RD, 1.5 [CI, Ϫ0.1 to 3.1] deaths per 1000 person-years) (Appendix Table 3 and Appendix Figure  1 , available at Annals.org).
Similar associations were found among participants with or without comorbid conditions at baseline (Appendix Tables 4 to 6, available at Annals.org) and those with high versus low nutrient intake from foods at baseline (Appendix Table 7 Table 8 and Appendix Figures 2 and 3 , available at Annals.org).
DISCUSSION
We found that dietary supplement use was not associated with mortality benefits in a nationally representative sample of U.S. adults. The evidence suggests that adequate nutrient intake from foods was associated with reduced mortality and excess intake from supplements could be harmful.
We initially found that any supplement use, MVM supplement use, and supplemental use of individual nutrients were each associated with lower risk for allcause death after adjustment for age, sex, and race/ ethnicity. However, most of the associations became statistically insignificant after additional adjustment for education and lifestyle factors. These results suggest that supplement use itself does not have direct health benefits. The apparent association between supplement use and lower mortality may reflect confounding by higher socioeconomic status and healthy lifestyle factors that are known to reduce mortality. Our results and those of others (18, 19) suggest that supplement users have higher levels of education and income and a healthier lifestyle overall (for example, better diet, higher levels of physical activity, no smoking or alcohol intake, and healthy weight) than nonusers. In addition, we and others (20, 21) found that supplement users had higher levels of nutrient intake from foods alone than nonusers. Thus, supplement users may have already had lower prevalence of nutrient inadequacy that contributed to lower mortality.
Our null findings are consistent with those from other recent cohort studies. For example, dietary supplement use was not associated with all-cause, CVD, or cancer death among 23 943 participants in the EPICHeidelberg (European Prospective Investigation into Cancer and Nutrition) study (22). Long-term multivitamin use was not associated with reduced incidence of or death due to stroke among 86 142 women in the NHS (Nurses' Health Study) (23). Similarly, systematic review of cohort studies and intervention trials does not support the benefits of supplement use for primary prevention of CVD or cancer (3, 24) . Although use of lycopene supplements was associated with lower risk for all-cause and cancer death in our study, prior evidence from prospective cohort studies does not support an association between lycopene-containing foods and cancer risk (25). Evidence from randomized controlled trials also does not support the chemopreventive role of lycopene supplements in prostate cancer (26, 27). Overall, the current evidence does not support mortality benefits associated with use of dietary supplements.
We found that the mortality benefits associated with adequate intake of some nutrients, such as vitamin A, vitamin K, magnesium, zinc, and copper, were restricted to intake from foods. There was also evidence that excess intake of some nutrients may have adverse effects. For example, we found higher cancer mortality with total calcium intake above the Tolerable Upper Intake Level. The potential harm of excess calcium intake has not been consistently reported (28), with some trials reporting reduced cancer risk with high intake (29 -Dietary Supplement Use, Nutrient Intake, and Mortality Among U.S. Adults ORIGINAL RESEARCH † RRs, RDs, and 95% CIs were adjusted for age, sex, race/ethnicity, education, physical activity, smoking, alcohol intake, Healthy Eating Index-2015 score, body mass index, presence of comorbid conditions at baseline, and NHANES survey weights. In models that included intake from both foods and supplements, each source was adjusted for the other. Multiple imputation was done for alcohol intake. RRs and RDs were not estimated for nutrients with <5 deaths in any intake subgroup. ‡ Adequate intake was defined as levels of nutrient intake at or above the EAR. RRs, RDs, and 95% CIs correspond to the comparisons between participants with total nutrient intake at or above versus below the EAR. For choline, vitamin K, potassium, and fiber, EARs were not available, so adequate intake was defined as intake at or above the Adequate Intake level. For EPA + DHA, adequate intake was defined as intake at or above that recommended by the Academy of Nutrition and Dietetics. § Models were also adjusted for presence of anemia at baseline (yes vs. no). ͉͉ Excess intake was defined as levels of nutrient intake above the UL. RRs, RDs, and 95% CIs correspond to comparisons between participants with total nutrient intake above versus at or below the UL. Few participants (<0.1%) had excess intake of nutrients from foods only.
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Dietary Supplement Use, Nutrient Intake, and Mortality Among U.S. Adults 31) and others raising concerns about its safety (32-34). For example, the HPFS (Health Professionals Follow-up Study) reported that total calcium intake of 1500 mg/d or higher was associated with increased risk for advanced or fatal prostate cancer among 47 750 men in the cohort (35). In a recent systematic review of 11 cohort studies, high total calcium intake was associated with increased risk for prostate cancer (relative risk, 1.11 [CI, 1.02 to 1.20]), and the association seemed stronger among persons followed for 10 or more years (relative risk, 1.22 [CI, 1.07 to 1.38]) (36). The underlying mechanisms are unclear and may involve stimulation of calcium-sensing receptors to promote secretion of parathyroid hormone-related protein, which could subsequently inhibit cell differentiation and alter proliferation (37). We further evaluated calcium intake from foods versus supplements and found increased cancer mortality only for high doses (≥1000 mg/d) from supplements rather than foods. These data are consistent with results from 59 744 men in the CPS-II Nutrition Cohort, where lower supplemental doses (<1000 mg/d) or calcium intake from foods did not increase risk, whereas higher supplemental doses (≥1000 mg/d) were associated with increased all-cause mortality (8) . The difference between calcium from supplements versus foods may be explained by the different effects on circulating calcium: High intake from foods can lead to reduced intestinal absorption and increased urinary excretion, whereas longterm supplement use does not diminish circulating calcium levels (34).
We found that vitamin D supplementation at doses above 10 mcg/d might be associated with increased all-cause and cancer death among persons without vitamin D deficiency. Whether vitamin D supplementation reduces premature death or prevents cancer is controversial. Prior meta-analysis of intervention trials suggests that vitamin D supplements may modestly reduce all-cause and cancer mortality (38), but recent trials did not support its role in preventing cancer or CVD (39 -41). The most recent trial, VITAL (Vitamin D and Omega-3 Trial), did not detect an effect of vitamin D supplements at a dose of 2000 IU/d on reducing cancer or CVD incidence among 25 817 participants during a median follow-up of 5.3 years (42). Potential benefits or harms of vitamin D supplement use need to be further evaluated.
Strengths of our study include use of a nationally representative sample of U.S. adults, longitudinal study design, and collection of data using validated measures. However, several limitations must be considered. First, dietary supplement use was assessed in the previous 30 days, which may not reflect habitual use or capture changes in use after baseline assessment. Prevalence and dosage of supplement use were based on self-report and so are subject to recall bias. However, NHANES documented that the ingredient and dosage information were obtained from the bottles and nutrition fact labels at the time of the interview 80% of the time (43), which reduces misclassification error due to recall bias.
Second, self-reported dietary intake is also subject to measurement error. NHANES incorporated one or two 24-hour diet recalls per person, which does not capture long-term intake because of large day-to-day variations in food intake. To improve the estimation of usual intake, we applied the NCI method to reduce measurement error associated with dietary intake estimated using diet recalls (44 -46). Measurement error cannot be ruled out, however, and is likely to be nondifferential (independent of mortality), which attenuates the associations.
Third, supplement use is highly correlated with participants' socioeconomic status and lifestyle factors, such as education, smoking, body mass index, alcohol intake, physical activity, and diet quality. Having chronic health conditions, such as cancer, CVD, hypertension, or diabetes, may also motivate initiation of dietary supplement use. To minimize the chance of residual confounding, we adjusted for all of these factors in the multivariable models. In addition, we stratified participants by presence of comorbid conditions at baseline, and the associations remained similar. However, supplement use may be associated with factors that we have Dietary Supplement Use, Nutrient Intake, and Mortality Among U.S. Adults ORIGINAL RESEARCH not identified and adjusted for, and residual confounding may still be present. Fourth, mortality outcomes were determined through linkage to the National Death Index via a probabilistic match (11) , which may have resulted in misclassification. A prior validation study showed that the method was highly accurate, with 96.1% of the decedents and 99.4% of the living participants classified correctly (47).
Fifth, given the limited sample size, we were unable to evaluate dietary supplement use and mortality from specific CVD conditions or cancer types or mortality due to conditions other than CVD or cancer.
Finally, we evaluated multiple nutrients, which can lead to spurious findings due to multiple comparisons. Humans consume foods and nutrients that are highly correlated. The complex interactions among nutrients are likely to play a more important role in determining health outcomes than individual nutrients. Thus, our findings on individual nutrients should be considered exploratory and interpreted with caution.
In conclusion, use of dietary supplements was not associated with mortality benefits among a nationally representative sample of U.S. adults. Although adequate nutrient intake from foods could contribute to reduced risk for death, excess intake from supplements might increase mortality. The potential risks and benefits of dietary supplement use for health need to be further evaluated in future studies. At each cycle, participants were asked during the household interview whether they had used any vitamins, minerals, or other dietary supplements in the previous 30 days. If the answer was yes, they were asked to show the containers to the interviewers, who recorded the product information, including the brand name and the product form (for example, tablets or capsules). If the participants could not show the containers, they were asked to recall the product information. More than 75% of the production information was recorded on the basis of information from the containers. Participants were then asked to report the number of days they took the product in the previous 30 days and the number of servings (for example, tablets, capsules, or drops) they usually took on days when they took it (48).
Data on supplement use are available from the following NHANES data files: 30-day total dietary supplement use, 30-day individual dietary supplement use, product information, ingredient information, and blend information. The first 2 files contain information on use of dietary supplements in the previous 30 days reported by each participant, and the last 3 contain information on the supplement brands, ingredients, amounts of the ingredients, and blends.
To estimate the daily dose of dietary supplements for each participant, we first estimated the number of different products used by each participant by multiplying the number of days by the number of serving size units used in the previous 30 days. We then associated each product in the product information data file with the ingredient in the information data file to identify the amount of vitamins, minerals, and nutrients in each serving size unit for each product. For proprietary blends, we used the blend information data file to disaggregate the ingredients.
To estimate the daily dose of nutrients that each participant received from multiple products, we summed the amount of each nutrient consumed from different products by multiplying the number of serving size units in the previous 30 days by the amount of nutrient per serving size for each product. We then divided the total amount by 30 days to estimate the daily dose of each supplemental nutrient taken by each participant. For example, for a participant who reported daily use of one 600-mg tablet of a single-ingredient calcium supplement for 20 days and 1 capsule of an MVM supplement containing 200 mg of calcium for 15 days, the total daily dose of supplemental calcium intake in the previous 30 days for that participant was estimated to be 500 mg/d in the past 30 days. This process was repeated for each ingredient of interest to estimate the daily nutrient intake from supplements for each participant.
APPENDIX 2: METHODS OF ESTIMATING USUAL INTAKE OF NUTRIENTS FROM FOODS
Nutrient intake from foods among NHANES participants was assessed using 24-hour diet recalls conducted by trained interviewers. One 24-hour diet recall was done in person at the Mobile Examination Center; from 2003 to 2010, a second recall was added by telephone interview approximately 3 to 10 days after the first recall. To estimate nutrient intake from foods, all foods and beverages reported in diet recalls were coded, and their nutrient values were determined using FNDDS, versions 1.0 to 5.0 (9) .
Dietary data from one or two 24-hour diet recalls may not represent a person's usual intake because of substantial within-person variability due to day-to-day variations in food intake. To correct for measurement error, we applied the NCI method to estimate usual intake of nutrients from foods (49). As documented in prior literature, the NCI method is the preferred method for estimating usual intake distribution from 24-hour diet recalls (17). It also uses regression calibration to correct for bias caused by measurement error in evaluating associations between usual intake and health outcomes (50).
We used a 2-step approach to estimate usual intake in the NCI method. The first step modeled the probability of consuming a given food or nutrient and the amount for foods or nutrients that are not consumed daily by most persons. Because most nutrients are consumed daily by nearly everyone, the amountonly model was used in the first step (MIXTRAN macro) for most nutrients. For nutrients that are episodically consumed, with more than 5% of the participants reporting zero intake on a given day (17), such as lycopene, eicosapentaenoic acid, docosahexaenoic acid, and added vitamin E, we used a 2-part model that estimated the probability of consumption and the amount.
The second step of the NCI method involves estimating usual intake with parameters estimated from the first step using mixed-effect linear regression on a transformed scale with a person-specific effect (INDIVINT macro) (49). The NCI method requires that some of the participants have multiple days of nutrient intake to estimate and separate within-and betweenperson variation (51). In our study, 17 189 also provided a second valid diet recall (62% of the 27 725 participants who provided a first valid recall). For each nutrient, the following covariates were specified for estimation of usual intake: an indicator of first-versus second-day diet recall, day of the week when recall occurred (weekday vs. weekend), use of dietary supplements (yes vs. no), age group (20 to 34, 35 to 49, 50 to 64, and ≥65 years), sex, and race/ethnicity (nonHispanic white, non-Hispanic black, Hispanic, and other). For the association analysis, we also included education, physical activity, smoking, alcohol intake, Healthy Eating Index-2015 score, body mass index, and presence of comorbid conditions at baseline.
To estimate the percentage of U.S. adults with adequate or excess nutrient intake, we compared the estimated usual intake with a predefined threshold, such as the Estimated Average Requirement or the Tolerable Upper Intake Level specified in the Dietary Reference Intakes (10) . As expected, the SEs associated with the estimated mean intake decreased after adjustment using the NCI method. Because the NCI method produces adjusted usual intake that is shrunk toward the sample mean, the estimated percentage of participants with nutrient intake below the Estimated Average Requirement or above the Tolerable Upper Intake Level was also smaller than that estimated without the NCI method. The associations between adequate or excess nutrient intake and mortality outcomes were largely similar before and after adjustment using the NCI method. † RRs, RDs, and 95% CIs were adjusted for age, sex, race/ethnicity, education, physical activity, smoking, alcohol intake, Healthy Eating Index-2015 score, body mass index, presence of comorbid conditions at baseline, and NHANES survey weights. In models that included intake from both foods and supplements, each source was adjusted for the other. Multiple imputation was done for alcohol intake. RRs and RDs were not estimated for nutrients with <5 deaths in any intake subgroup. ‡ Adequate intake was defined as levels of nutrient intake at or above the EAR. RRs, RDs, and 95% CIs correspond to the comparisons between participants with total nutrient intake at or above versus below the EAR. For choline, vitamin K, potassium, and fiber, EARs were not available, so adequate intake was defined as intake at or above the Adequate Intake level. For EPA + DHA, adequate intake was defined as intake at or above that recommended by the Academy of Nutrition and Dietetics. § Models were also adjusted for presence of anemia at baseline (yes vs. no).
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͉͉ Excess intake was defined as levels of nutrient intake above the UL. RRs, RDs, and 95% CIs correspond to the comparisons between participants with total nutrient intake above versus at or below the UL. Few participants (<0.1%) had excess intake of nutrients from foods only. Association of Nutrient Intake From Foods Versus Supplements and Cancer Mortality † RRs, RDs, and 95% CIs were adjusted for age, sex, race/ethnicity, education, physical activity, smoking, alcohol intake, Healthy Eating Index-2015 score, body mass index, presence of comorbid conditions at baseline, and NHANES survey weights. In models that included intake from both foods and supplements, each source was adjusted for the other. Multiple imputation was done for alcohol intake. RRs and RDs were not estimated for nutrients with <5 deaths in any intake subgroup. ‡ Adequate intake was defined as levels of nutrient intake at or above the EAR. RRs, RDs, and 95% CIs correspond to the comparisons between participants with total nutrient intake at or above versus below the EAR. For choline, vitamin K, potassium, and fiber, EARs were not available, so adequate intake was defined as intake at or above the Adequate Intake level. For EPA + DHA, adequate intake was defined as intake at or above that recommended by the Academy of Nutrition and Dietetics. § Models were also adjusted for presence of anemia at baseline (yes vs. no).
͉͉ Excess intake was defined as levels of nutrient intake above the UL. RRs, RDs, and 95% CIs correspond to the comparisons between participants with total nutrient intake above versus at or below the UL. Few participants (<0.1%) had excess intake of nutrients from foods only. 0/163 -CVD = cardiovascular disease; DHA = docosahexaenoic acid; EPA = eicosapentaenoic acid; MVM = multivitamin and mineral; NHANES = National Health and Nutrition Examination Survey; RR = rate ratio.
* RRs and 95% CIs were adjusted for age, sex, race/ethnicity, education, physical activity, smoking, alcohol intake, Healthy Eating Index-2015 score, body mass index, and NHANES survey weights. Multiple imputation was done for alcohol intake. RRs and 95% CIs for CVD and cancer mortality were not estimated for zeaxanthin, omega-6, and omega-9 because no CVD deaths or cancer deaths occurred for supplement users without comorbid conditions. † Also adjusted for presence of anemia at baseline (yes vs. no). AI = Adequate Intake; CVD = cardiovascular disease; DHA = docosahexaenoic acid; EAR = Estimated Average Requirement; EPA = eicosapentaenoic acid; NHANES = National Health and Nutrition Examination Survey; RR = rate ratio.
* RRs and 95% CIs were adjusted for age, sex, race/ethnicity, education, physical activity, smoking, alcohol intake, Healthy Eating Index-2015 score, body mass index, and NHANES survey weights. Multiple imputation was done for alcohol intake. RRs and 95% CIs were not estimated for several nutrients because no deaths occurred among participants without comorbid conditions with nutrient intakes at or above the EAR or below the EAR. † The classifications of choline, vitamin K, potassium, and fiber were based on AI level (at or above vs. below the AI level). The classification of EPA + DHA was based on daily intake recommended by the Academy of Nutrition and Dietetics (at or above vs. below the recommended intake). ‡ Also adjusted for presence of anemia at baseline (yes vs. no). CVD = cardiovascular disease; NHANES = National Health and Nutrition Examination Survey; RR = risk ratio; UL = Tolerable Upper Intake Level.
Intake of vitamin
* RRs and 95% CIs were adjusted for age, sex, race/ethnicity, education, physical activity, smoking, alcohol intake, Healthy Eating Index-2015 score, body mass index, and NHANES survey weights. Multiple imputation was done for alcohol intake. RRs and 95% CIs were not estimated for several nutrients because 1 or no deaths occurred among participants (with and/or without comorbid conditions) with nutrient intakes above the UL. † UL applies to preformed vitamin A only. ‡ UL applies to synthetic forms obtained from supplements, fortified foods, or a combination of the two. § UL applies to any form of supplemental ␣-tocopherol. ¶ UL represents intake from a pharmacologic agent only and does not include intake from food and water. 25-(OH)D = 25-hydroxyvitamin D; CVD = cardiovascular disease; NHANES = National Health and Nutrition Examination Survey; RD = rate difference; RR = rate ratio. * RRs, RDs, and 95% CIs were adjusted for age, sex, race/ethnicity, education, physical activity, smoking, alcohol intake, Healthy Eating Index-2015 score, body mass index, presence of comorbid conditions at baseline, and NHANES survey weights. Multiple imputation was done for alcohol intake.
